Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2013, Article ID 193830, 4 pages
http://dx.doi.org/10.1155/2013/193830
Case Report

Mycobacterium interjectum Lung Infection

1Division of Pulmonary Medicine, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA
2Division of Pulmonary Medicine and Infectious Disease, Mayo Clinic Florida, USA

Received 26 May 2013; Accepted 19 August 2013

Academic Editors: D. Franzen and C. Y. Tu

Copyright © 2013 M. C. Mirant-Borde et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Springer, P. Kirschner, G. Rost-Meyer, K. H. Schröder, R. M. Kroppenstedt, and E. C. Böttger, “Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis,” Journal of Clinical Microbiology, vol. 31, no. 12, pp. 3083–3089, 1993, Erratum in Journal of Clinical Microbiology, vol. 32, no. 5, p. 1417, 1994. View at Google Scholar
  2. D. Tuerlinckx, M. Fauville-Dufaux, E. Bodart, P. Bogaerts, B. Dupont, and Y. Glupczynski, “Submandibular lymphadenitis caused by Mycobacterium interjectum: contribution of new diagnostic tools,” European Journal of Pediatrics, vol. 169, no. 4, pp. 505–508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. de Baere, M. Moerman, L. Rigouts et al., “Mycobacterium interjectum as causative agent of cervical lymphadenitis,” Journal of Clinical Microbiology, vol. 39, no. 2, pp. 725–727, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Remacha, A. Esteban, M. I. Parra, and M. S. Jiménez, “Case report—cervical lymphadenitis due to mycobacterium interjectum,” Pediatric Pulmonology, vol. 42, no. 4, pp. 398–399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rose, R. Kitz, A. Mischke, R. Enzensberger, V. Schneider, and S. Zielen, “Lymphadenitis cervicalis due to Mycobacterium interjectum in immunocompetent children,” Acta Paediatrica, vol. 93, no. 3, pp. 424–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Rustscheff, L. Maroti, M. Holberg-Petersen, M. Steinbakk, and S. E. Hoffner, “Mycobacterium interjectum: a new pathogen in humans?” Scandinavian Journal of Infectious Diseases, vol. 32, no. 5, pp. 569–571, 2000. View at Google Scholar · View at Scopus
  7. B. A. Green and B. Afessa, “Isolation of Mycobacterium interjectum in an AIDS patient with diarrhea,” AIDS, vol. 14, no. 9, pp. 1282–1284, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Tortoli, P. Kirschner, A. Bartoloni et al., “Isolation of an unusual mycobacterium from an AIDS patient,” Journal of Clinical Microbiology, vol. 34, no. 9, pp. 2316–2319, 1996. View at Google Scholar · View at Scopus
  9. M. Fukuoka, Y. Matsumura, S. Kore-Eda, Y. Iinuma, and Y. Miyachi, “Cutaneous infection due to Mycobacterium interjectum in an immunosuppressed patient with microscopic polyangiitis,” The British Journal of Dermatology, vol. 159, no. 6, pp. 1382–1384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Emler, T. Rochat, P. Rohner et al., “Chronic destructive lung disease associated with a novel mycobacterium,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 1, pp. 261–265, 1994. View at Google Scholar · View at Scopus
  11. J. M. Lacasa, E. Cuchi, and R. Font, “Mycobacterium interjectum as a cause of lung disease mimicking tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 13, no. 8, p. 1048, 2009. View at Google Scholar · View at Scopus
  12. R. Lumb, A. Goodwin, R. Ratcliff, R. Stapledon, A. Holland, and I. Bastian, “Phenotypic and molecular characterization of three clinical isolates of Mycobacterium interjectum,” Journal of Clinical Microbiology, vol. 35, no. 11, pp. 2782–2785, 1997. View at Google Scholar · View at Scopus
  13. S. Ehlers and E. Richter, “Differential requirement for interferon-γ to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo,” Clinical and Experimental Immunology, vol. 124, no. 2, pp. 229–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Tortoli, A. Bartoloni, C. Burrini et al., “Characterization of an isolate of the newly described species Mycobacterium interjectum,” Zentralblatt für Bakteriologie, vol. 283, no. 3, pp. 286–294, 1996. View at Google Scholar · View at Scopus
  15. D. Harmsen, S. Dostal, A. Roth et al., “RIDOM: comprehensive and public sequence database for identification of Mycobacterium species,” BMC Infectious Diseases, vol. 3, article 26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Häfner, H. Haag, H.-K. Geiss, and O. Nolte, “Different molecular methods for the identification of rarely isolated non-tuberculous mycobacteria and description of new hsp65 restriction fragment length polymorphism patterns,” Molecular and Cellular Probes, vol. 18, no. 1, pp. 59–65, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Holland, “Immunotherapy of mycobacterial infections,” Seminars in Respiratory Infections, vol. 16, no. 1, pp. 47–59, 2001. View at Google Scholar · View at Scopus